Islet autotransplantation to preserve beta cell mass in selected patients with chronic pancreatitis and diabetes mellitus undergoing total pancreatectomy

Pancreas

Volumn 42, Issue 2, 2013, Pages 317-321

  Bellin, Melena D ^a,b   Beilman, Gregory J ^b   Dunn, Ty B ^b   Pruett, Timothy L ^b   Chinnakotla, Srinath ^b   Wilhelm, Joshua J ^a   Ngo, Anh ^c   Radosevich, David M ^b   Freeman, Martin L ^d   Schwarzenberg, Sarah J ^b   Balamurugan, A N ^a   Hering, Bernhard J ^a   Sutherland, David E R ^a,b  

^a Schulze Diabetes Institute   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Des Moines University College of Osteopathic Medicine   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

beta cell; diabetes; islet; pancreatitis; transplant

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CELL ISOLATION; CHRONIC PANCREATITIS; CLINICAL ARTICLE; DIET RESTRICTION; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; OUTCOME ASSESSMENT; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; TEST MEAL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-PEPTIDE; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATITIS, CHRONIC; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874106374     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182681182     Document Type: Article

References (18)

1. Blondet JJ, Carlson AM, Kobayashi T, et al. The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Surg Clin North Am. 2007;87:1477-1501.
2. Sutherland DE, Gruessner AC, Carlson AM, et al. Islet autotransplant outcomes after total pancreatectomy: A contrast to islet allograft outcomes. Transplantation. 2008;86:1799-1802.
3. Cui Y, Andersen DK. Pancreatogenic diabetes: Special considerations for management. Pancreatology. 2011;11:279-294.
4. Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004;2:252-261.
5. Malka D, Hammel P, Sauvanet A, et al. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology. 2000;119: 1324-1332.
6. Larsen S. Diabetes mellitus secondary to chronic pancreatitis. Dan Med Bull. 1993;40(2):153-162.
7. Dresler CM, Fortner JG, McDermott K, et al. Metabolic consequences of (regional) total pancreatectomy. Ann Surg. 1991; 214:131-140.
8. Ali MA, Dayan CM. Review: The importance of residual endogenous beta-cell preservation in type 1 diabetes. Br J Diabetes Vasc Dis. 2009;9:248-253.
9. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group. Ann Intern Med. 1998;128:517-523.
10. Bellin MD, Freeman ML, Schwarzenberg SJ, et al. Quality of life improves for pediatric patients after total pancreatectomy and islet autotransplant for chronic pancreatitis. Clin Gastroenterol Hepatol. 2011;9:793-799.
11. Bellin MD, Sutherland DE. Pediatric islet autotransplantation: Indication, technique, and outcome. Curr Diab Rep. 2010;10:326-331.
12. Lakey JR, Warnock GL, Shapiro AM, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant. 1999;8:285-292.
13. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes. 1989;38(suppl 1):140-142.
14. CITR coordinating center. Collaborative islet transplant registry: 6th annual report. November 1, 2009. Available at http://citregistry.org;/. Accessed December 1, 2012.
15. Ong SL, Gravante G, Pollard CA, et al. Total pancreatectomy with islet autotransplantation: An overview. HPB (Oxford). 2009;11:613-621.
16. Kawahara T, Kin T, Kashkoush S, et al. Portal vein thrombosis is a potentially preventable complication in clinical islet transplantation. Am J Transplant. 2011;12:2700-2707.
17. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest. 2006;116:1802-1812.
18. Bonora E. Protection of pancreatic beta-cells: Is it feasible? Nutr Metab Cardiovasc Dis. 2008;18:74-83.